Clinical exome sequencing uncovers an unsuspected diagnosis of Bartter syndrome type 2 in a child with incidentally detected nephrocalcinosis
Authors:
- 23 February 2022
- journal article
- case report
- Published by Springer Nature in CEN Case Reports
- Vol. 11 (4) , 417-421
Abstract
Nephrocalcinosis is a characteristic feature of both type 1 and type 2 Bartter syndrome. Bartter syndrome type 2 presents antenatally and very early in life. Late-onset presentation with isolated nephrocalcinosis is extremely rare. We describe an 11-year-old girl with incidentally detected medullary nephrocalcinosis on renal ultrasonography. She was clinically suspected to have primary hyperoxaluria based on high urine oxalate. However, clinical exome sequencing revealed a pathogenic missense variant in the KCNJ1 gene leading to the molecular diagnosis of Bartter syndrome type 2. Both parents were heterozygous carriers of the same variant. Subsequent investigations did reveal a mild Bartter syndrome phenotype with mild metabolic alkalosis, high urine chloride and high renin and aldosterone. Our case illustrates phenotypic heterogeneity of Bartter syndrome type 2 and the usefulness of genetic testing in establishing the correct diagnosis and guiding further management in such cases.Keywords
This publication has 17 references indexed in Scilit:
- Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or NephrocalcinosisClinical Journal of the American Society of Nephrology, 2016
- Whole exome sequencing identifies causative mutations in the majority of consanguineous or familial cases with childhood-onset increased renal echogenicityKidney International, 2016
- Development of a Targeted Multi-Disorder High-Throughput Sequencing Assay for the Effective Identification of Disease-Causing VariantsPLOS ONE, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Fourteen Monogenic Genes Account for 15% of Nephrolithiasis/NephrocalcinosisJournal of the American Society of Nephrology, 2015
- Identification of compound heterozygous KCNJ1 mutations (encoding ROMK) in a kindred with Bartter's syndrome and a functional analysis of their pathogenicityPhysiological Reports, 2013
- A novel compound heterozygous ROMK mutation presenting as late onset Bartter syndrome associated with nephrocalcinosis and elevated 1,25(OH)2 vitamin D levelsClinical and Experimental Nephrology, 2011
- A comprehensive guide to the ROMK potassium channel: form and function in health and diseaseAmerican Journal of Physiology-Renal Physiology, 2009
- Urolithiasis and Nephrocalcinosis in Childhood2008
- Two novel mutations of the gene for Kir 1.1 (ROMK) in neonatal Bartter syndromePediatric Nephrology, 1998